Did FDA-Approved Hugo Robot and New Diabetes Tech Just Shift Medtronic's (MDT) Investment Narrative?

In early December 2025, Medtronic’s board approved a US$0.71 per-share cash dividend for the third quarter of fiscal 2026, payable on January 16, 2026, and the company secured FDA clearance for its ...
The Edge Singapore

Humanoid robot maker Galbot said to pick banks for 2026 Hong Kong IPO — Bloomberg

Galbot, a Chinese manufacturer of robots with human-like characteristics, is considering an initial public offering (IPO) in ...